These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 17652175)
1. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Fiala M; Liu PT; Espinosa-Jeffrey A; Rosenthal MJ; Bernard G; Ringman JM; Sayre J; Zhang L; Zaghi J; Dejbakhsh S; Chiang B; Hui J; Mahanian M; Baghaee A; Hong P; Cashman J Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12849-54. PubMed ID: 17652175 [TBL] [Abstract][Full Text] [Related]
2. Immune defects in Alzheimer's disease: new medications development. Cashman JR; Ghirmai S; Abel KJ; Fiala M BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S13. PubMed ID: 19090986 [TBL] [Abstract][Full Text] [Related]
3. Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside. Fiala M CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):192-6. PubMed ID: 20205641 [TBL] [Abstract][Full Text] [Related]
4. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. Masoumi A; Goldenson B; Ghirmai S; Avagyan H; Zaghi J; Abel K; Zheng X; Espinosa-Jeffrey A; Mahanian M; Liu PT; Hewison M; Mizwickie M; Cashman J; Fiala M J Alzheimers Dis; 2009; 17(3):703-17. PubMed ID: 19433889 [TBL] [Abstract][Full Text] [Related]
5. Curcumins promote monocytic gene expression related to β-amyloid and superoxide dismutase clearance. Cashman JR; Gagliardi S; Lanier M; Ghirmai S; Abel KJ; Fiala M Neurodegener Dis; 2012; 10(1-4):274-6. PubMed ID: 22156608 [TBL] [Abstract][Full Text] [Related]
6. Evaluation in vitro of synthetic curcumins as agents promoting monocytic gene expression related to β-amyloid clearance. Gagliardi S; Ghirmai S; Abel KJ; Lanier M; Gardai SJ; Lee C; Cashman JR Chem Res Toxicol; 2012 Jan; 25(1):101-12. PubMed ID: 22029407 [TBL] [Abstract][Full Text] [Related]
7. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids. Fiala M; Mahanian M; Rosenthal M; Mizwicki MT; Tse E; Cho T; Sayre J; Weitzman R; Porter V J Alzheimers Dis; 2011; 25(1):135-44. PubMed ID: 21368380 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E Polymorphism and Oxidative Stress in Peripheral Blood-Derived Macrophage-Mediated Amyloid-Beta Phagocytosis in Alzheimer's Disease Patients. Jairani PS; Aswathy PM; Krishnan D; Menon RN; Verghese J; Mathuranath PS; Gopala S Cell Mol Neurobiol; 2019 Apr; 39(3):355-369. PubMed ID: 30694418 [TBL] [Abstract][Full Text] [Related]
9. Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease. Gagliardi S; Franco V; Sorrentino S; Zucca S; Pandini C; Rota P; Bernuzzi S; Costa A; Sinforiani E; Pansarasa O; Cashman JR; Cereda C Front Pharmacol; 2018; 9():1404. PubMed ID: 30559668 [TBL] [Abstract][Full Text] [Related]
10. Immune blood biomarkers of Alzheimer disease patients. Avagyan H; Goldenson B; Tse E; Masoumi A; Porter V; Wiedau-Pazos M; Sayre J; Ong R; Mahanian M; Koo P; Bae S; Micic M; Liu PT; Rosenthal MJ; Fiala M J Neuroimmunol; 2009 May; 210(1-2):67-72. PubMed ID: 19329192 [TBL] [Abstract][Full Text] [Related]
11. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. Zhang L; Fiala M; Cashman J; Sayre J; Espinosa A; Mahanian M; Zaghi J; Badmaev V; Graves MC; Bernard G; Rosenthal M J Alzheimers Dis; 2006 Sep; 10(1):1-7. PubMed ID: 16988474 [TBL] [Abstract][Full Text] [Related]
12. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. Fiala M; Lin J; Ringman J; Kermani-Arab V; Tsao G; Patel A; Lossinsky AS; Graves MC; Gustavson A; Sayre J; Sofroni E; Suarez T; Chiappelli F; Bernard G J Alzheimers Dis; 2005 Jun; 7(3):221-32; discussion 255-62. PubMed ID: 16006665 [TBL] [Abstract][Full Text] [Related]
13. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Ahmed T; Enam SA; Gilani AH Neuroscience; 2010 Sep; 169(3):1296-306. PubMed ID: 20538041 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors in Alzheimer's disease: a therapeutic perspective. Gambuzza ME; Sofo V; Salmeri FM; Soraci L; Marino S; Bramanti P CNS Neurol Disord Drug Targets; 2014; 13(9):1542-58. PubMed ID: 25106635 [TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of different curcuminoids on β-amyloid protein, β-amyloid precursor protein and β-site amyloid precursor protein cleaving enzyme 1 in swAPP HEK293 cells. Liu H; Li Z; Qiu D; Gu Q; Lei Q; Mao L Neurosci Lett; 2010 Nov; 485(2):83-8. PubMed ID: 20727383 [TBL] [Abstract][Full Text] [Related]
16. MyD88 acts as an adaptor protein for inflammatory signalling induced by amyloid-β in macrophages. O'Halloran S; O'Leary A; Kuijper T; Downer EJ Immunol Lett; 2014 Nov; 162(1 Pt A):109-18. PubMed ID: 25124962 [TBL] [Abstract][Full Text] [Related]
17. Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. Mizwicki MT; Menegaz D; Zhang J; Barrientos-Durán A; Tse S; Cashman JR; Griffin PR; Fiala M J Alzheimers Dis; 2012; 29(1):51-62. PubMed ID: 22207005 [TBL] [Abstract][Full Text] [Related]